<SEC-DOCUMENT>0001213900-25-122793.txt : 20251217
<SEC-HEADER>0001213900-25-122793.hdr.sgml : 20251217
<ACCEPTANCE-DATETIME>20251217161008
ACCESSION NUMBER:		0001213900-25-122793
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251217
DATE AS OF CHANGE:		20251217

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIUS ONCOLOGY, INC.
		CENTRAL INDEX KEY:			0001851484
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				994362660
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93794
		FILM NUMBER:		251579373

	BUSINESS ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016
		BUSINESS PHONE:		(908) 967-6677

	MAIL ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		FIRST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TenX Keane Acquisition
		DATE OF NAME CHANGE:	20210315

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citius Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001506251
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				273425913
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016
		BUSINESS PHONE:		(908) 967-6676

	MAIL ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Trail One, Inc.
		DATE OF NAME CHANGE:	20110314

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TrailOne, Inc.
		DATE OF NAME CHANGE:	20101119
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Citius Pharmaceuticals, Inc. -->
          <cik>0001506251</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>3</amendmentNo>
      <securitiesClassTitle>Common Shares, $0.0001 par value per share</securitiesClassTitle>
      <dateOfEvent>12/10/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001851484</issuerCIK>
        <issuerCUSIP>17331Y109</issuerCUSIP>
        <issuerName>Citius Oncology, Inc.</issuerName>
        <address>
          <com:street1>11 Commerce Drive, First Floor</com:street1>
          <com:city>Cranford</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>07016</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Leonard L. Mazur CEO</personName>
          <personPhoneNum>(908) 967-6677</personPhoneNum>
          <personAddress>
            <com:street1>11 Commerce Drive,</com:street1>
            <com:street2>1st Floor</com:street2>
            <com:city>Cranford</com:city>
            <com:stateOrCountry>NJ</com:stateOrCountry>
            <com:zipCode>07016</com:zipCode>
          </personAddress>
        </notificationInfo>
        <notificationInfo>
          <personName>Alexander M. Donaldson, Esq.</personName>
          <personPhoneNum>(919) 781-4000</personPhoneNum>
          <personAddress>
            <com:street1>4101 Lake Boone Trail, Suite 300</com:street1>
            <com:city>Raleigh</com:city>
            <com:stateOrCountry>NC</com:stateOrCountry>
            <com:zipCode>27607</com:zipCode>
          </personAddress>
        </notificationInfo>
        <notificationInfo>
          <personName>Lorna A. Knick, Esq.</personName>
          <personPhoneNum>(919) 781-4000</personPhoneNum>
          <personAddress>
            <com:street1>4101 Lake Boone Trail, Suite 300</com:street1>
            <com:city>Raleigh</com:city>
            <com:stateOrCountry>NC</com:stateOrCountry>
            <com:zipCode>27607</com:zipCode>
          </personAddress>
        </notificationInfo>
        <notificationInfo>
          <personName>Wyrick Robbins Yates &amp; Ponton</personName>
          <personPhoneNum>(919) 781-4000</personPhoneNum>
          <personAddress>
            <com:street1>4101 Lake Boone Trail, Suite 300</com:street1>
            <com:city>Raleigh</com:city>
            <com:stateOrCountry>NC</com:stateOrCountry>
            <com:zipCode>27607</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001506251</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Citius Pharmaceuticals, Inc.</reportingPersonName>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>66049615.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>66049615.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>66049615.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>77.9</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>CO</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Shares, $0.0001 par value per share</securityTitle>
        <issuerName>Citius Oncology, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>11 Commerce Drive, First Floor</com:street1>
          <com:city>Cranford</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>07016</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>EXPLANATORY NOTE

On December 10, 2025, the Issuer sold and issued 1,284,404 shares of its common stock, $0.0001 par value per share, in a registered direct offering.

This Amendment No. 3 to the Schedule 13D of the Reporting Person filed on August 16, 2024, as amended on July 25, 2025, and September 12, 2025, amends and supplements the Schedule 13D as specifically set forth herein, to give effect to the issuance of the shares on December 10, 2025.</commentText>
      </item1>
      <item5>
        <percentageOfClassSecurities>The Reporting Person is the beneficial owner of 66,049,615 shares of the Issuer's common stock, which represents approximately 77.9% of the Issuer's outstanding common stock, based upon 84,797,846 shares of common stock outstanding as of December 10, 2025.</percentageOfClassSecurities>
        <numberOfShares>The Reporting Person has sole voting and dispositive power of 66,049,615 shares of the Issuer's common stock beneficially owned.</numberOfShares>
      </item5>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Citius Pharmaceuticals, Inc.</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Leonard Mazur</signature>
          <title>Leonard Mazur, Chief Executive Officer</title>
          <date>12/17/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
